LT2268292T - Vėžio gydymo būdai ir kompozicijos - Google Patents

Vėžio gydymo būdai ir kompozicijos

Info

Publication number
LT2268292T
LT2268292T LTEP09723788.7T LT09723788T LT2268292T LT 2268292 T LT2268292 T LT 2268292T LT 09723788 T LT09723788 T LT 09723788T LT 2268292 T LT2268292 T LT 2268292T
Authority
LT
Lithuania
Prior art keywords
cancer
compositions
treatment
Prior art date
Application number
LTEP09723788.7T
Other languages
English (en)
Lithuanian (lt)
Inventor
Angelika Burger
Hans Hendriks
Bernardus Rademaker
Original Assignee
Kominox, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox, Inc. filed Critical Kominox, Inc.
Publication of LT2268292T publication Critical patent/LT2268292T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP09723788.7T 2008-03-27 2009-03-24 Vėžio gydymo būdai ir kompozicijos LT2268292T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3998708P 2008-03-27 2008-03-27
US12/408,864 US20090246291A1 (en) 2008-03-27 2009-03-23 Method and compositions for treatment of cancer
PCT/US2009/038104 WO2009120697A2 (en) 2008-03-27 2009-03-24 Method and compositions for treatment of cancer

Publications (1)

Publication Number Publication Date
LT2268292T true LT2268292T (lt) 2018-03-26

Family

ID=41114644

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP09723788.7T LT2268292T (lt) 2008-03-27 2009-03-24 Vėžio gydymo būdai ir kompozicijos

Country Status (20)

Country Link
US (2) US20090246291A1 (enExample)
EP (1) EP2268292B1 (enExample)
JP (2) JP5543956B2 (enExample)
KR (1) KR101634138B1 (enExample)
CN (2) CN104997808A (enExample)
AU (1) AU2009228378B2 (enExample)
BR (1) BRPI0909164A2 (enExample)
CA (1) CA2719766C (enExample)
CY (1) CY1120536T1 (enExample)
DK (1) DK2268292T3 (enExample)
ES (1) ES2656762T3 (enExample)
HU (1) HUE036609T2 (enExample)
LT (1) LT2268292T (enExample)
MX (1) MX2010010621A (enExample)
PL (1) PL2268292T3 (enExample)
PT (1) PT2268292T (enExample)
RU (1) RU2508116C2 (enExample)
SI (1) SI2268292T1 (enExample)
WO (1) WO2009120697A2 (enExample)
ZA (1) ZA201006988B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
AU2010292192B2 (en) * 2009-09-10 2015-04-02 Kominox, Inc. Cancer stem cell-targeted and drug resistant cancer therapy
US8795738B2 (en) * 2009-11-12 2014-08-05 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US11084811B2 (en) 2010-03-01 2021-08-10 Oncternal Therapeutics, Inc. Compounds for treatment of cancer
CN103153303A (zh) * 2010-07-18 2013-06-12 尼基制药公司 使用钌络合物的联合疗法
RU2762111C1 (ru) * 2010-08-24 2021-12-15 Юниверсити Оф Теннесси Рисерч Фаундейшн Соединения для лечения рака
US20120251628A1 (en) * 2011-03-30 2012-10-04 Young Joo Min Compositions and methods for treatment of cancer
US8834938B2 (en) 2011-05-18 2014-09-16 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
WO2012155061A1 (en) * 2011-05-12 2012-11-15 Board Of Regents, University Of Texas System Use of arsenic for cancer therapy protection
US20160184356A1 (en) * 2013-03-15 2016-06-30 Ke Jian Jim Liu Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko) 2013-03-15 2013-09-23 박상채 항암 활성 증진용 한약재 및 이의 제조방법
JP6851826B2 (ja) * 2013-07-19 2021-03-31 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． がんの治療のためのｐｉｍキナーゼ阻害剤と組み合わせたペプチドエポキシケトンプロテアソーム阻害剤
IL265986B (en) * 2016-12-01 2022-09-01 Eupharma Pty Ltd Pharmaceutical composition comprising an alkali metal and/or an alkaline earth metal diarsenic (iii) tetraoxide and uses thereof
BR112020019425A2 (pt) 2018-03-22 2020-12-29 Komipharm International Australia Pty Ltd Composição farmacêutica compreendendo meta-arsenito e método de fabricação
CN116236505A (zh) * 2023-03-15 2023-06-09 上海市第四人民医院 三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875451B2 (en) * 1997-10-15 2005-04-05 Polarx Biopharmaceuticals Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
ES2395515T3 (es) * 1997-11-10 2013-02-13 Memorial Sloan Kettering Cancer Center Trióxido de arsénico para uso en el tratamiento de la leucemia
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
DK2042182T3 (da) * 2002-04-10 2013-08-26 Komipharm Int Co Ltd Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet.
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) * 2005-08-23 2012-01-17 Stc.Unm Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
WO2009049258A1 (en) * 2007-10-12 2009-04-16 The Johns Hopkins University Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

Also Published As

Publication number Publication date
KR101634138B1 (ko) 2016-06-28
US20090246291A1 (en) 2009-10-01
RU2010143893A (ru) 2012-05-10
ES2656762T3 (es) 2018-02-28
WO2009120697A3 (en) 2010-02-18
MX2010010621A (es) 2011-04-05
EP2268292B1 (en) 2017-12-27
CN104997808A (zh) 2015-10-28
AU2009228378A1 (en) 2009-10-01
CN102046187A (zh) 2011-05-04
JP5543956B2 (ja) 2014-07-09
SI2268292T1 (en) 2018-03-30
AU2009228378B2 (en) 2014-07-17
RU2508116C2 (ru) 2014-02-27
JP2011515481A (ja) 2011-05-19
CY1120536T1 (el) 2019-07-10
JP2014101387A (ja) 2014-06-05
KR20110009664A (ko) 2011-01-28
BRPI0909164A2 (pt) 2016-06-21
HUE036609T2 (hu) 2018-07-30
US20180055812A1 (en) 2018-03-01
ZA201006988B (en) 2012-05-30
EP2268292A4 (en) 2011-05-11
PL2268292T3 (pl) 2018-06-29
WO2009120697A2 (en) 2009-10-01
DK2268292T3 (en) 2018-03-12
EP2268292A2 (en) 2011-01-05
PT2268292T (pt) 2018-02-19
CA2719766C (en) 2017-10-31
CA2719766A1 (en) 2009-10-01
WO2009120697A4 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
ZA201006988B (en) Method and compositions for treatment of cancer
IL267342B (en) Antibodies and preparations containing them for the treatment of cancer
IL218987A0 (en) Methods and compositions for treating cancer
PL2340042T3 (pl) Sposoby i kompozycje do leczenia raka
PL2200431T3 (pl) Nowe kompozycje i metody służące leczeniu raka
SG10201510152RA (en) Diagnostic methods and compositions for treatment of cancer
SG10201402491YA (en) Methods and compositions for diagnosis and treatment of cancer
HUE062354T2 (hu) Módosított humán arginázokat tartalmazó készítmények és eljárások rák kezelésére
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL214349A0 (en) Compositions and methods for the treatment of cancer
IL199689A0 (en) Compounds and method for treatment of cancer
EP2176406A4 (en) COMPOSITIONS AND METHOD FOR CANCER TREATMENT
EP2225226A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2515652A4 (en) COMPOSITIONS AND METHODS FOR TREATING VITILIGO
IL196727A0 (en) Composition and method for treatment of tumors
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
LT3067054T (lt) Naujos kompozicijos ir būdai vėžiui gydyti